Study of Serum Albumin Levels and Their Link to Hepatic Encephalopathy Severity in Adults with Chronic Liver Disease at Sohag University Hospital

What this Trial Is About

This research aims to evaluate the relationship between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. It also seeks to understand how albumin levels affect the clinical course and outcomes of hepatic encephalopathy. The study plans to include 100 to 150 patients to ensure reliable statistical results. Participants will undergo a thorough clinical assessment including Glasgow Coma Scale scoring and evaluation of chronic liver disease complications such as ascites and variceal bleeding. Medical history details such as prior hepatic encephalopathy episodes, liver disease causes, and other health conditions will be recorded. Laboratory tests will measure serum albumin, liver enzymes, bilirubin, blood counts, kidney function, and blood clotting parameters. During the study, researchers will collect and analyze clinical and laboratory data to assess correlations. The primary outcome is the correlation between serum albumin levels and hepatic encephalopathy severity over a six-month period. Participants will be monitored carefully to understand how albumin impacts their disease progression and clinical outcomes.

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital